Amylocaine (CHEM071220)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-04-04 03:41:47 UTC | ||||||||
| Update Date | 2026-08-19 07:10:47 UTC | ||||||||
| Accession Number | CHEM071220 | ||||||||
| Identification | |||||||||
| Common Name | Amylocaine | ||||||||
| Class | Small Molecule | ||||||||
| Description | Amylocaine is an organic compound with the chemical formula C14H21N1O2 and an average molecular weight of 235.33 g/mol. Amylocaine belongs to the benzoic acids and derivatives, a subclass of benzene and substituted derivatives within the organic compounds. It is further classified under the superclass of benzenoids. In terms of its biological activity, there are 10 recorded protein targets for this compound. Amylocaine acts as a blocker of several sodium channel proteins, specifically Sodium channel protein type 1 subunit alpha (SCN1A), Sodium channel protein type 4 subunit alpha (SCN4A), Sodium channel protein type 7 subunit alpha (SCN7A), and Sodium channel protein type 5 subunit alpha (SCN5A), as well as 6 other proteins. | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C14H21N1O2 | ||||||||
| Average Molecular Mass | 235.327 g/mol | ||||||||
| Monoisotopic Mass | 235.157 g/mol | ||||||||
| CAS Registry Number | 644-26-8 | ||||||||
| IUPAC Name | 1-(Dimethylamino)-2-methylbutan-2-yl benzoate | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | CCC(C)(CN(C)C)OC(=O)C1=CC=CC=C1 | ||||||||
| InChI Identifier | InChI=1S/C14H21NO2/c1-5-14(2,11-15(3)4)17-13(16)12-9-7-6-8-10-12/h6-10H,5,11H2,1-4H3 | ||||||||
| InChI Key | FDMBBCOBEAVDAO-UHFFFAOYSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways |
| ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
